share_log

Acumen Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ives Jeffrey L.

SEC announcement ·  Aug 18, 2023 18:31
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more